Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px
Document › Details

InflaRx N.V.. (5/17/18). "Press Release: InflaRx N.V. Reports First Quarter 2018 Financial & Operating Results". Jena.

Organisations Organisation InflaRx N.V. (Nasdaq Global Select Market: IFRX)
  Group InflaRx (Group)
  Organisation 2 LifeSci Advisors LLC
  Group LifeSci (Group)
Products Product IFX-1 (InflaRx)
  Product 2 clinical research
Index term Index term InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share
Persons Person Christ, Arnd (Immatics 202010– CFO before InflaRx + Proteros + MediGene + NovImmune + Probiodrug + Hoechst)
  Person 2 Gibney, Tony (FogPharma 202005– CBO + CFO before Achillion Pharma + Leerink Partners + Merrill Lynch + Lehman Brothers)
     


   
Record changed: 2018-06-07

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for InflaRx (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC D Meet Top Investors 650x300px




» top